An Investigational Immuno-therapy Safety Trial of Nivolumab in Patients With Advanced or Metastatic Renal Cell Carcinoma
Public ClinicalTrials.gov record NCT02596035. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3b/4 Safety Trial of Nivolumab (BMS-936558) in Subjects With Advanced or Metastatic Renal Cell Carcinoma (CheckMate 374: CHECKpoint Pathway and Nivolumab Clinical Trial Evaluation 374)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study will generate safety data on Nivolumab given by itself in treatment of advanced Renal Cell Carcinoma (RCC). The primary objective of this study is to assess immune related side effects, also known as immune-mediated adverse events (IMAEs), in patients treated with Nivolumab.
Study identification
- NCT ID
- NCT02596035
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 197 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 8, 2016 (Actual)
- Primary completion
- Mar 19, 2018 (Actual)
- Completion
- May 24, 2021 (Actual)
- Last update posted
- Oct 27, 2022
2016 – 2021
United States locations
- U.S. sites
- 39
- U.S. states
- 19
- U.S. cities
- 38
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Local Institution - 0030 | Phoenix | Arizona | 85016 | — |
| Comprehensive Blood And Cancer Center | Bakersfield | California | 93309 | — |
| St. Jude Hospital Yorba Linda | Fullerton | California | 92835 | — |
| Cancer Care Associates Medical Group, Inc. | Redondo Beach | California | 90277 | — |
| Sansum Santa Barbara Medical Foundation Clinic | Santa Barbara | California | 93105 | — |
| University Of Colorado | Aurora | Colorado | 80045 | — |
| Local Institution - 0028 | Grand Junction | Colorado | 81501 | — |
| Local Institution - 0018 | Lakewood | Colorado | 80228 | — |
| Local Institution - 0008 | Fort Myers | Florida | 33901 | — |
| Baptist Health Medical Group Oncology | Miami | Florida | 33176 | — |
| Local Institution - 0007 | St. Petersburg | Florida | 33705 | — |
| Local Institution - 0054 | Tampa | Florida | 33612-9497 | — |
| Illinois Cancer Specialists | Niles | Illinois | 60714 | — |
| Local Institution - 0052 | Fort Wayne | Indiana | 46845 | — |
| Norton Cancer Institute | Louisville | Kentucky | 40202 | — |
| Sidney Kimmel Comprehensive Cancer Center At Johns Hopkins | Baltimore | Maryland | 21231 | — |
| HCA Midwest Division | Kansas City | Missouri | 64132 | — |
| Southeast Nebraska Hematology & Oncology Consultants, P.C. | Lincoln | Nebraska | 68510 | — |
| Local Institution - 0011 | Omaha | Nebraska | 68130 | — |
| Urology Cancer Center Laboratory | Omaha | Nebraska | 68130 | — |
| Local Institution - 0014 | Las Vegas | Nevada | 89169 | — |
| Local Institution - 0053 | Buffalo | New York | 14263 | — |
| Broome Oncology | Johnson City | New York | 13790 | — |
| Local Institution - 0055 | New York | New York | 10065 | — |
| Local Institution - 0001 | Tulsa | Oklahoma | 74146 | — |
| Local Institution - 0016 | Portland | Oregon | 97213-2982 | — |
| Local Institution - 0020 | Charleston | South Carolina | 29414 | — |
| Local Institution - 0005 | Chattanooga | Tennessee | 37404 | — |
| Local Institution - 0012 | Germantown | Tennessee | 38138 | — |
| Local Institution - 0004 | Nashville | Tennessee | 37203 | — |
| Local Institution - 0015 | Dallas | Texas | 75246 | — |
| The Center For Cancer And Blood Disorders | Fort Worth | Texas | 76104 | — |
| Local Institution - 0034 | Houston | Texas | 77024 | — |
| Local Institution - 0021 | San Antonio | Texas | 78217 | — |
| Texas Cancer Center - Sherman | Sherman | Texas | 75090-0504 | — |
| Local Institution - 0032 | Norfolk | Virginia | 23502 | — |
| Local Institution - 0047 | Richmond | Virginia | 23230 | — |
| Local Institution - 0017 | Roanoke | Virginia | 24014 | — |
| Local Institution - 0039 | Seattle | Washington | 98109 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02596035, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 27, 2022 · Synced Oct 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02596035 live on ClinicalTrials.gov.